Supplemental material - Multiparametric magnetic resonance imaging discerns glioblastoma immune microenvironmental heterogeneity

Autor: Kersch, Cymon N, Muldoon, Leslie L, Claunch, Cheryl J, Fu, Rongwei, Schwartz, Daniel, Cha, Soonmee, Starkey, Jay, Neuwelt, Edward A, Barajas, Ramon F

Supplemental material for Multiparametric magnetic resonance imaging discerns glioblastoma immune microenvironmental heterogeneity by Cymon N Kersch, Leslie L Muldoon, Cheryl J Claunch, Rongwei Fu, Daniel Schwartz, Soonmee Cha, Jay Starkey, Edward A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50ae31613789dd9c1d0e58b6463da514

Strategies to improve predictions of outcome in glioblastoma multiforme and muscle-invasive bladder cancer

Autor: Claunch, Cheryl J.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4863a2f90c61a7288bef8890ac043ba5

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Transcriptional signatures in histologic structures within glioblastoma tumors may predict personalized drug sensitivity and survival.

Autor: Kersch CN; Department of Neurology, Blood-Brain Barrier Program, Oregon Health and Science University, Portland, Oregon, USA., Claunch CJ; Department of Biomedical Engineering, OHSU Center for Spatial Systems Biomedicine, Oregon Health and Science University, Portland, Oregon, USA.; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Ambady P; Department of Neurology, Blood-Brain Barrier Program, Oregon Health and Science University, Portland, Oregon, USA., Bucher E; Department of Biomedical Engineering, OHSU Center for Spatial Systems Biomedicine, Oregon Health and Science University, Portland, Oregon, USA.; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Schwartz DL; Advanced Imaging Research Center, Oregon Health and Science University, Portland, Oregon, USA.; Department of Neurology, Layton Aging and Alzheimer's Disease Center, Oregon Health and Science University, Portland, Oregon, USA., Barajas RF Jr; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.; Advanced Imaging Research Center, Oregon Health and Science University, Portland, Oregon, USA.; Department of Radiology, Oregon Health and Science University, Portland, Oregon, USA., Iliff JJ; Department of Neurology and Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, USA., Risom T; Department of Pathology, Stanford University, Stanford, California, USA., Heiser L; Department of Biomedical Engineering, OHSU Center for Spatial Systems Biomedicine, Oregon Health and Science University, Portland, Oregon, USA.; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Muldoon LL; Department of Neurology, Blood-Brain Barrier Program, Oregon Health and Science University, Portland, Oregon, USA., Korkola JE; Department of Biomedical Engineering, OHSU Center for Spatial Systems Biomedicine, Oregon Health and Science University, Portland, Oregon, USA.; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Gray JW; Department of Biomedical Engineering, OHSU Center for Spatial Systems Biomedicine, Oregon Health and Science University, Portland, Oregon, USA.; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Neuwelt EA; Department of Neurology, Blood-Brain Barrier Program, Oregon Health and Science University, Portland, Oregon, USA.; Department of Neurosurgery, Oregon Health and Science University, Portland, Oregon, USA.; Office of Research and Development, Department of Veterans Affairs Medical Center, Portland, Oregon, USA.

Publikováno v: Neuro-oncology advances [Neurooncol Adv] 2020 Aug 03; Vol. 2 (1), pp. vdaa093. Date of Electronic Publication: 2020 Aug 03 (Print Publication: 2020).